A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

Clinical trial NCT07729462 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07729462
Sponsor: Pfizer
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Preventive Treatment of Migraine

Start date: 2026-07-29
Primary completion: 2028-09-12
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.